Connect with us

Announcements

CannTrust Board of Directors Fires CEO with Cause, and Chair Requested to Resign

Published

on

CannTrust Board of Directors Fires CEO with Cause, and Chair Requested to Resign

Canadian-based, federally-licensed medical cannabis provider, CannTrust announced on Thursday, July 25, that changes were in place for the senior management after an investigation was conducted by a Special Committee and the firm’s Board of Directors.

In particular, this resulted in firing CEO, Peter Aceto with cause, and asking Chair, Eric Paul to step down from his position, to which the latter accepted the resignation reports Cision.

As for the reason behind the investigation, it seems like the firm might have not complied by the regulations imposed by Health Canada. According to news outlet, Mugglehead, Health Canada identified that CannTrust was illegally growing cannabis in five unlicensed rooms in Ontario between October 2018 and March 2019.

Since the removal of two key players within CannTrust, both positions have since been filled by Special Committee Chair, Robert Marcovitch (as an interim CEO) and Mark Dawber (Special Committee Chair).

Marcovitch has since voiced the following:

“Our first priority is to complete the remaining items of our investigation and bring the Company’s operations into full regulatory compliance,” adding that the firm has a, “number of strengths it can draw upon to reset and rebuild, including industry-leading research, innovation and intellectual property.”

A day after news regarding the changes made to the senior management (Friday, July 26), Market Watch reported that its stock, CTST, shot up by roughly 15% in after-hours trading. This is coming after the firm supposedly lost over 60% of its value in the past month since being called out for illegally growing their source of marijuana.

Continue Reading

Ultimate CBD Guide


Disclaimer

ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email contact@timesofcbd.com

Copyright © 2020 TimesofCBD.com | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.